Efficacy of IARULIL® in the Treatment of Recurrent Cystitis Refractory to Escherichia Coli Extract

Recurrent Cystitis Clinical Trial

Official title:
Efficacy of Combined Intravesical Therapy With Hyaluronic Acid and Chondroitin Sulphate in the Treatment of Recurrent Cystitis Refractory to Escherichia Coli Extract: a Multicenter, Prospective Study

Status Completed

Clinical Trial Summary

The purpose of this study is to evaluate the efficacy of Combined Intravesical Therapy With Hyaluronic Acid and Chondroitin Sulphate in the Treatment of Recurrent Cystitis Refractory to Escherichia Coli Extract

Clinical Trial Description

The purpose of this study is to evaluate the efficacy of combined intravesical therapy with hyaluronic acid and chondroitin sulphate(IARULIL®) in the treatment of recurrent cystitis refractory to oral Escherichia Coli extract(Uro-Vaxom®) and the change of urinary tract infection symptoms after intravesical instillation treatment with IARULIL®. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02366676
Study type	Interventional
Source	Samsung Medical Center
Contact
Status	Completed
Phase	Phase 4
Start date	January 2014
Completion date	October 30, 2019

View Details

See also
	Status	Clinical Trial	Phase
	Completed	`NCT04962971` - Comparative Effect of 3 Different Cranberry Extracts on Cystitis Related Urinary Comfort in Women